Literature DB >> 21277543

Retraction--Validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trial.

Hervé Bonnefoi1, Anil Potti, Mauro Delorenzi, Louis Mauriac, Mario Campone, Michèle Tubiana-Hulin, Thierry Petit, Philippe Rouanet, Jacek Jassem, Emmanuel Blot, Véronique Becette, Pierre Farmer, Sylvie André, Chaitanya R Acharya, Sayan Mukherjee, David Cameron, Jonas Bergh, Joseph R Nevins, Richard D Iggo.   

Abstract

Entities:  

Year:  2011        PMID： 21277543     DOI： 10.1016/S1470-2045(11)70011-0

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  4 in total

Review 1.  Breast cancer classification and prognostication through diverse systems along with recent emerging findings in this respect; the dawn of new perspectives in the clinical applications.

Authors:  Vida Pourteimoor; Samira Mohammadi-Yeganeh; Mahdi Paryan
Journal:  Tumour Biol       Date:  2016-09-20

2.  Microarray-based oncogenic pathway profiling in advanced serous papillary ovarian carcinoma.

Authors:  Xuan Bich Trinh; Wiebren A A Tjalma; Luc Y Dirix; Peter B Vermeulen; Dieter J Peeters; Dimcho Bachvarov; Marie Plante; Els M Berns; Jozien Helleman; Steven J Van Laere; Peter A van Dam
Journal:  PLoS One       Date:  2011-07-25       Impact factor: 3.240

3.  Intra- and interspecies gene expression models for predicting drug response in canine osteosarcoma.

Authors:  Jared S Fowles; Kristen C Brown; Ann M Hess; Dawn L Duval; Daniel L Gustafson
Journal:  BMC Bioinformatics       Date:  2016-02-19       Impact factor: 3.169

4.  Genome-wide analysis of the three-way interplay among gene expression, estrogen receptor expression and chemotherapeutic sensitivity in breast cancer.

Authors:  Dong-Xu He; Xiao-Li Wu; Chun-Xiao Lu; Xiao-Ting Gu; Guang-Yuan Zhang; Xin Ma; De-Quan Liu
Journal:  Oncol Rep       Date:  2017-10-12       Impact factor: 3.906
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.